Does the NIPT Test Tell You the Gender?
Learn how NIPT reveals fetal sex with high accuracy. Understand cell‑free DNA screening, gender results timing, and when to order a prenatal screening panel.
Yes, the NIPT (non‑invasive prenatal testing) test can tell you the fetal gender with more than 99% accuracy for a singleton pregnancy when performed after 10 weeks of gestation. This blood‑based screening analyzes cell‑free DNA fragments from the placenta circulating in the mother’s bloodstream. By detecting the presence of Y‑chromosome sequences, the test reliably indicates whether the baby is male (XY) or female (XX). In 2026, NIPT remains the most sensitive and earliest routine screening method for fetal sex, offered as part of a comprehensive prenatal screening panel.
What Is NIPT and How Does It Determine Gender?
NIPT—short for non‑invasive prenatal testing—is a screening tool that examines cell‑free DNA (cfDNA) in maternal blood. Unlike diagnostic procedures such as chorionic villus sampling (CVS) or amniocentesis, NIPT carries no risk of miscarriage and can be performed as early as the 10th week of pregnancy. The test looks for extra or missing chromosomes (e.g., trisomy 21, 18, 13) and, simultaneously, counts sex chromosomes. If Y‑chromosome sequences are found, the result is male; if absent, female.
Accuracy and Limitations of NIPT Gender Results
Studies consistently report that NIPT correctly identifies fetal sex in over 99% of cases when the fetal fraction—the proportion of cfDNA from the placenta—is sufficient (typically ≥4%). However, rare factors can affect accuracy:
- Vanishing twin – A twin that stopped developing early may release Y‑chromosome DNA, causing a false male result.
- Maternal conditions – Organ transplant from a male donor or a prior male pregnancy (rarely) can leave residual Y‑chromosome fragments.
- Low fetal fraction – If the fetal fraction is too low, the test may not yield a gender result and may need a redraw.
Because NIPT is a screening test, not a diagnostic one, confirmatory testing with CVS or amniocentesis is recommended if gender results are critical for medical reasons, such as X‑linked disorders.
When Can You Learn the Gender via NIPT?
Most laboratories report NIPT results within 5–10 business days after the blood draw. Since the test is performed from 10 weeks onward, many parents receive their gender result by the end of the first trimester—well before the anatomy ultrasound at 18–20 weeks. This early insight is one reason NIPT is popular among expectant parents.
NIPT vs. Other Prenatal Tests for Gender
Other prenatal screening methods can also indicate fetal sex, but NIPT offers distinct advantages:
| Test Type | When Performed | Gender Accuracy | Risk |
|---|---|---|---|
| NIPT (cell‑free DNA) | From 10 weeks | >99% | None (blood draw) |
| First‑trimester screening (ultrasound + blood) | 11–13 weeks | ~70–80% (ultrasound) | None |
| Quad screen | 15–20 weeks | Not designed for gender | None |
| Integrated screening | First + second trimester | Not designed for gender | None |
| Chorionic villus sampling (CVS) | 10–13 weeks | >99% (diagnostic) | Small miscarriage risk (~0.2%) |
| Amniocentesis | 15–20 weeks | >99% (diagnostic) | Small miscarriage risk (~0.1%) |
While carrier screening and prenatal paternity tests are separate services, NIPT remains the top choice for early, safe gender determination as part of a broader genetic health check.
What NIPT Does Not Tell You
It is important to understand that NIPT is not a diagnostic test. A result indicating “female” means no Y‑chromosome was detected, but it does not guarantee the absence of rare sex‑chromosome variations (e.g., Turner syndrome, Klinefelter syndrome). A genetic counselor can help interpret results and discuss follow‑up options. Additionally, NIPT does not screen for all genetic conditions—carrier screening for disorders like SMA, fragile X, or cystic fibrosis requires a separate test.
Ordering a Comprehensive Prenatal Screening Panel
If you are ready to learn your baby’s gender while also screening for common chromosomal conditions, consider a comprehensive prenatal screening panel that includes NIPT. These panels combine cell‑free DNA analysis with carrier screening for conditions such as spinal muscular atrophy (SMA), fragile X syndrome, and cystic fibrosis. Results are typically available within 7–10 days after your blood sample is received. To get started, order a prenatal screening panel online and receive your results quickly from a CLIA‑certified laboratory.
Ready to get screened? Order a prenatal carrier screening panel online through our partner and visit a local lab near you.
Order Prenatal Carrier ScreeningAbout PrenatalScreenings
PrenatalScreenings.com is a local lab information directory. We do not provide medical advice, diagnose conditions, or interpret test results. Always consult a qualified healthcare provider for personal medical guidance.